'
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Report Guidance 5
Clinical Trials by Region 6
Clinical Trials and Average Enrollment by Country 7
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Zollinger-Ellison Syndrome (Gastrinoma) to Gastrointestinal Clinical Trials 15
Clinical Trials by Phase in G7 Countries 17
Clinical Trials in G7 Countries by Trial Status 18
Clinical Trials by E7 Countries: Proportion of Zollinger-Ellison Syndrome (Gastrinoma) to Gastrointestinal Clinical Trials 19
Clinical Trials by Phase in E7 Countries 20
Clinical Trials in E7 Countries by Trial Status 21
Clinical Trials by Phase 22
In Progress Trials by Phase 23
Clinical Trials by Trial Status 24
Clinical Trials by End Point Status 25
Subjects Recruited Over a Period of Time 26
Clinical Trials by Sponsor Type 27
Prominent Sponsors 28
Top Companies Participating in Zollinger-Ellison Syndrome (Gastrinoma) Therapeutics Clinical Trials 29
Prominent Drugs 31
Clinical Trial Profile Snapshots 32
Appendix 109
Abbreviations 109
Definitions 109
Research Methodology 110
Secondary Research 110
About GlobalData 111
Contact Us 111
Disclaimer 111
Source 112
List of Tables
Zollinger-Ellison Syndrome (Gastrinoma) Therapeutics, Global, Clinical Trials by Region, 2016* 6
Zollinger-Ellison Syndrome (Gastrinoma) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016* 8
Zollinger-Ellison Syndrome (Gastrinoma) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2016* 9
Zollinger-Ellison Syndrome (Gastrinoma) Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2016* 10
Zollinger-Ellison Syndrome (Gastrinoma) Therapeutics Clinical Trials, Europe, Top Five Countries, 2016* 11
Zollinger-Ellison Syndrome (Gastrinoma) Therapeutics Clinical Trials, North America, Top Countries, 2016* 12
Zollinger-Ellison Syndrome (Gastrinoma) Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2016* 13
Zollinger-Ellison Syndrome (Gastrinoma) Therapeutics Clinical Trials, Central and South America, Top Countries, 2016* 14
Proportion of Zollinger-Ellison Syndrome (Gastrinoma) to Gastrointestinal Clinical Trials, G7 Countries (%), 2016* 16
Zollinger-Ellison Syndrome (Gastrinoma) Therapeutics, G7 Countries, Clinical Trials by Phase, 2016* 17
Zollinger-Ellison Syndrome (Gastrinoma) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2016* 18
Proportion of Zollinger-Ellison Syndrome (Gastrinoma) to Gastrointestinal Clinical Trials, E7 Countries (%), 2016* 19
Zollinger-Ellison Syndrome (Gastrinoma) Therapeutics, E7 Countries, Clinical Trials by Phase, 2016* 20
Zollinger-Ellison Syndrome (Gastrinoma) Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2016* 21
Zollinger-Ellison Syndrome (Gastrinoma) Therapeutics, Global, Clinical Trials by Phase, 2016* 22
Zollinger-Ellison Syndrome (Gastrinoma) Therapeutics, Global, Clinical Trials In Progress by Phase 2016* 23
Zollinger-Ellison Syndrome (Gastrinoma) Therapeutics, Global, Clinical Trials by Trial Status, 2016* 24
Zollinger-Ellison Syndrome (Gastrinoma) Therapeutics Clinical Trials, Global, by End Point Status, 2016* 25
Zollinger-Ellison Syndrome (Gastrinoma) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2011-2015 26
Zollinger-Ellison Syndrome (Gastrinoma) Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2016* 27
Zollinger-Ellison Syndrome (Gastrinoma) Therapeutics Clinical Trials, Global, Key Sponsors, 2016* 28
Zollinger-Ellison Syndrome (Gastrinoma) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016* 30
Zollinger-Ellison Syndrome (Gastrinoma) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2016* 31
List of Figures
Zollinger-Ellison Syndrome (Gastrinoma) Therapeutics, Global, Clinical Trials by Region (%), 2016* 6
Zollinger-Ellison Syndrome (Gastrinoma) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016* 7
Zollinger-Ellison Syndrome (Gastrinoma) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2016* 9
Zollinger-Ellison Syndrome (Gastrinoma) Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2016* 10
Zollinger-Ellison Syndrome (Gastrinoma) Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2016* 11
Zollinger-Ellison Syndrome (Gastrinoma) Therapeutics Clinical Trials, North America, Top Countries (%), 2016* 12
Zollinger-Ellison Syndrome (Gastrinoma) Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2016* 13
Zollinger-Ellison Syndrome (Gastrinoma) Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2016* 14
Proportion of Zollinger-Ellison Syndrome (Gastrinoma) to Gastrointestinal Clinical Trials, G7 Countries (%), 2016* 15
Zollinger-Ellison Syndrome (Gastrinoma) Therapeutics, G7 Countries, Clinical Trials by Phase, 2016* 17
Zollinger-Ellison Syndrome (Gastrinoma) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2016* 18
Proportion of Zollinger-Ellison Syndrome (Gastrinoma) to Gastrointestinal Clinical Trials, E7 Countries (%), 2016* 19
Zollinger-Ellison Syndrome (Gastrinoma) Therapeutics, E7 Countries, Clinical Trials by Phase, 2016* 20
Zollinger-Ellison Syndrome (Gastrinoma) Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2016* 21
Zollinger-Ellison Syndrome (Gastrinoma) Therapeutics, Global, Clinical Trials by Phase (%), 2016* 22
Zollinger-Ellison Syndrome (Gastrinoma) Therapeutics, Global, Clinical Trials In Progress by Phase, 2016* 23
Zollinger-Ellison Syndrome (Gastrinoma) Therapeutics, Global, Clinical Trials by Trial Status, 2016* 24
Zollinger-Ellison Syndrome (Gastrinoma) Therapeutics Clinical Trials, Global, by End Point Status, 2016* 25
Zollinger-Ellison Syndrome (Gastrinoma) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2011-2015 26
Zollinger-Ellison Syndrome (Gastrinoma) Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2016* 27
Zollinger-Ellison Syndrome (Gastrinoma) Therapeutics Clinical Trials, Global, Key Sponsors, 2016* 28
Zollinger-Ellison Syndrome (Gastrinoma) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016* 29
Zollinger-Ellison Syndrome (Gastrinoma) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2016* 31
GlobalData Methodology 110